glp 1 pills eli lilly to seek approval of new GLP-1 weight-loss drug this year Eli Lilly, the maker of

Why this matters GLP-1 is on the tip of many peoples tongues because medications that act on the GLP-1 receptor produce strong effects on appetite, weight, and blood sugar

A study by Pickart et al

In our review, we summarize evidence from randomized clinical trials and meta-analyses showing that ten approved and emerging obesity medications can improve a remarkably broad range of obesity-related conditions, including: Liver disease (MASLD and MASH) Chronic kidney disease PCOS (now increasingly referred to as PMOS, polyendocrine metabolic-ovarian syndrome) Obstructive sleep apnoea Osteoarthritis and physical functioning Cardiovascular disease Prediabetes and type 2 diabetes Importantly, many of these benefits are related to weight loss itself

The peptide's neuroprotective effects also warrant attention